Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sunshine Biopharma (SBFMW) Gross Profit (2018 - 2025)

Historic Gross Profit for Sunshine Biopharma (SBFMW) over the last 8 years, with Q3 2025 value amounting to $3.1 million.

  • Sunshine Biopharma's Gross Profit rose 723.58% to $3.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.3 million, marking a year-over-year increase of 2144.05%. This contributed to the annual value of $10.7 million for FY2024, which is 2794.79% up from last year.
  • Per Sunshine Biopharma's latest filing, its Gross Profit stood at $3.1 million for Q3 2025, which was up 723.58% from $3.4 million recorded in Q2 2025.
  • In the past 5 years, Sunshine Biopharma's Gross Profit registered a high of $3.4 million during Q2 2025, and its lowest value of $21538.0 during Q1 2021.
  • Its 5-year average for Gross Profit is $1.6 million, with a median of $2.0 million in 2023.
  • Its Gross Profit has fluctuated over the past 5 years, first skyrocketed by 615761.05% in 2022, then soared by 723.58% in 2025.
  • Over the past 5 years, Sunshine Biopharma's Gross Profit (Quarter) stood at $23829.0 in 2021, then soared by 6157.61% to $1.5 million in 2022, then soared by 72.22% to $2.6 million in 2023, then rose by 20.44% to $3.1 million in 2024, then fell by 0.63% to $3.1 million in 2025.
  • Its Gross Profit was $3.1 million in Q3 2025, compared to $3.4 million in Q2 2025 and $2.7 million in Q1 2025.